sorafenib has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, J; Chen, YL; Ding, X; Gai, L; Li, HP; Xu, L; Xu, Q; Ye, XL; Zhang, L; Zhang, X; Zhang, YX | 1 |
1 other study(ies) available for sorafenib and Idiopathic Pulmonary Fibrosis
Article | Year |
---|---|
Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
Topics: Alveolar Epithelial Cells; Animals; Apoptosis; Bleomycin; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Extracellular Matrix; Female; Fibroblasts; HEK293 Cells; Humans; Idiopathic Pulmonary Fibrosis; Male; Mice; Mice, Inbred C57BL; Niacinamide; NIH 3T3 Cells; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Sorafenib; Transforming Growth Factor beta1 | 2013 |